BCM
OM icon

BlueCrest Capital Management’s Outset Medical OM Stock Holding History

BlueCrest Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-820
Closed -$226K – 288
2023
Q1 		$226K Buy
+820
New +$301K 0.01% 246

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlueCrest Capital Management's OM Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Outset Medical (OM) in Q2 2023, closing a stake of 820 shares — an estimated $226K sold.

BlueCrest Capital Management first reported a position in OM in Q1 2023 and held it in 1 quarter. The position peaked at $226K in Q1 2023. 154 funds tracked by Wall St. Rank hold OM as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Outset Medical position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 820 Outset Medical shares in Q2 2023, an estimated $226K.
  • BlueCrest Capital Management first reported a position in Outset Medical in Q1 2023 and held it in 1 quarter.
  • BlueCrest Capital Management's Outset Medical position peaked at $226K in Q1 2023.
  • 154 funds tracked by Wall St. Rank held Outset Medical as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.